comprehensive -WSS

comprehensive

author：knowledge 2025-09-27 23:53:00 - browse：41

President of Bayer U.S. Sebastian Guth speaks with STAT reporters at STAT's Boston headquarters, March 13, 2024 — Bayer's U.S. president, Sebastian Guth, emphasized at an interview at the STAT offices in Boston that the pharma company is no longer just focused on small molecules. Alissa Ambrose/STAT

German pharmaceutical company Bayer is expanding its U.S. pharma business significantly, despite corporate turmoil and pricing pressures that have led many in the drug industry to bemoan the potential end of the American biotech innovation boom.

Bayer’s C-suite has been on a soul-searching mission for the last year, spurred by new leadership and the realization that the company is, as new CEO Bill Anderson said earlier this month, “badly broken.”

The biggest fissure is the debt and litigation costs stemming from Bayers’s 2018 acquisition of agriculture firm Monsanto, but the aspirin-maker’s pharmaceutical portfolio is also facing strain. Some of Bayer’s top products, including the anticoagulant drug Xarelto and the eye medication Eylea, are under patent pressure. Xarelto is also one of the first drugs to be subject to Medicare price negotiations under the Inflation Reduction Act, though Johnson & Johnson owns U.S. rights to the drug.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： A revolution in caring for preterm infants

entertainment

WSS

Akero's treatment for NASH falls short in cirrhosis study

Kidney disease boosts cardiac arrest risk for Hispanics, Latinos

STAT Readout Newsletter: Today in biotech, life science news

UnitedHealth’s Q3 profit jumps as medical costs rise more slowly

How artificial intelligence is being used to detect, treat cancer

Humana CEO Bruce Broussard to step down in 2024

explore

comprehensive

knowledge

How to save PrEP access — and even expand it

Nick Jonas talks about managing diabetes along with his career

Walensky prepares to leave CDC — and Congress — behind

Takeaways from AdvaMed, the largest medical devices conference

DIEP, the 'gold standard' of breast reconstruction, is under threat

In new study, freeze

The high cost of giving birth even with insurance

In new study, freeze

New air purifier tech could be key to improving indoor air quality

A fraught question for the kids of Alzheimer’s: Is it coming for us?

explore

Death toll from an explosion and collapse of a Paris building in June climbs to 3

Southern California school board OKs curriculum after Gov. Gavin Newsom threatened a $1.5M fine

UnitedHealth’s Q3 profit jumps as medical costs rise more slowly

Will.i.am, Britney Spears release new single, 'Mind Your Business'

Humana CEO Bruce Broussard to step down in 2024

AbbVie dramatically boosts its spending on lobbying

entertainment

focus

focus

entertainment